Literature DB >> 26393203

Langerhans Cell Expression in Oral Submucous Fibrosis: An Immunohistochemical Analysis.

Bharghavi Narayanan1, Malathi Narasimhan2.   

Abstract

INTRODUCTION: Langerhans cells (LCs), are dendritic cells of the epithelium which play a role in an array of oral lesions from gingivitis to oral cancer. Oral Submucous Fibrosis (OSMF), a potentially malignant disorder (PMD), is an insidious chronic disease with juxta-epithelial inflammatory changes leading to fibrosis. Langerhans cells (LCs) may play a part in the ongoing inflammatory dysregulation of OSMF.
OBJECTIVE: The study was aimed at elucidating the distribution of LCs in varying grades of OSMF.
MATERIALS AND METHODS: A retrospective study using 39 cases of OSMF, graded using Haematoxylin and Eosin (H&E) stained section. Immunohistochemistry was performed using polyclonal anti- CD1a antibodies to identify LCs in 5 cases of normal tissue and 39 samples of OSMF. The distribution of LCs among the various grades and normal mucosa analysed using Mann-Whitney U test.
RESULTS: LC population in the OSMF was significantly higher when compared to the normal epithelium (p<0.001). Within the grades the advanced stage had more LCs than the other stages.
CONCLUSION: The increase in LCs might indicate the role of antigenic exposure in turn leading to cell mediated immunity in OSMF. Thus the fibrosis in OSMF might have a direct link to LCs.

Entities:  

Keywords:  CD1a; Cell mediated immunity; Dendritic cells

Year:  2015        PMID: 26393203      PMCID: PMC4573035          DOI: 10.7860/JCDR/2015/12608.6196

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  13 in total

1.  Quantitative analysis of immunocompetent cells in oral submucous fibrosis in Taiwan.

Authors:  C P Chiang; H Y Wu; B Y Liu; J T Wang; M Y P Kuo
Journal:  Oral Oncol       Date:  2002-01       Impact factor: 5.337

Review 2.  Oral submucous fibrosis: review on aetiology and pathogenesis.

Authors:  W M Tilakaratne; M F Klinikowski; Takashi Saku; T J Peters; Saman Warnakulasuriya
Journal:  Oral Oncol       Date:  2005-11-28       Impact factor: 5.337

3.  An immunohistochemical study of oral submucous fibrosis.

Authors:  M F Haque; M Harris; S Meghji; P M Speight
Journal:  J Oral Pathol Med       Date:  1997-02       Impact factor: 4.253

4.  Immunolocalization of cytokines and growth factors in oral submucous fibrosis.

Authors:  M F Haque; M Harris; S Meghji; A W Barrett
Journal:  Cytokine       Date:  1998-09       Impact factor: 3.861

Review 5.  Langerhans cells: structure, function and role in oral pathological conditions.

Authors:  T Lombardi; C Hauser; E Budtz-Jörgensen
Journal:  J Oral Pathol Med       Date:  1993-05       Impact factor: 4.253

Review 6.  Cytokine expression by epidermal cell subpopulations.

Authors:  H Matsue; P D Cruz; P R Bergstresser; A Takashima
Journal:  J Invest Dermatol       Date:  1992-11       Impact factor: 8.551

7.  Hypertrophic scar formation is associated with an increased number of epidermal Langerhans cells.

Authors:  Frank B Niessen; Joost Schalkwijk; Hans Vos; Wim Timens
Journal:  J Pathol       Date:  2004-01       Impact factor: 7.996

8.  Expression of CD1a and CD86 on scleroderma Langerhans cells.

Authors:  Yong Xie; Xiaoyong Zhang; Yuji Inoue; Shouji Wakasugi; Takamitsu Makino; Hironobu Ihn
Journal:  Eur J Dermatol       Date:  2007-12-18       Impact factor: 3.328

9.  Pathophysiology of Langerhans cells.

Authors:  Shweta Jaitley; Tr Saraswathi
Journal:  J Oral Maxillofac Pathol       Date:  2012-05

10.  Association between langerhans cells population and histological grade of oral squamous cell carcinoma.

Authors:  Taye J Lasisi; Abideen O Oluwasola; Olawale A Lasisi; Effiong E Akang
Journal:  J Oral Maxillofac Pathol       Date:  2013-09
View more
  2 in total

1.  Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jerome R Lechien; Imelda Seminerio; Géraldine Descamps; Quentin Mat; Francois Mouawad; Stéphane Hans; Morbize Julieron; Didier Dequanter; Thibault Vanderhaegen; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

2.  Early antitumor activity of oral Langerhans cells is compromised by a carcinogen.

Authors:  Yasmin Saba; Itay Aizenbud; Daniela Matanes; Noam Koren; Or Barel; Khalid Zubeidat; Tal Capucha; Eyal David; Luba Eli-Berchoer; Patrizia Stoitzner; Asaf Wilensky; Ido Amit; Rakefet Czerninski; Simon Yona; Avi-Hai Hovav
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-18       Impact factor: 12.779

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.